What they do:

Clarrio is an AI-enabled, fully interoperable real-world data platform designed to provide continuous, longitudinal visibility into patients with chronic diseases beyond clinical settings. The platform aggregates multimodal data including physiological, behavioral, environmental, and patient-reported inputs into a unified, interoperable system that integrates seamlessly with existing healthcare infrastructures.

By structuring this data over time, Clarrio enables the identification of patterns, trends, and cohort-level correlations, supporting a deeper understanding of disease trajectories, patient experience, and real-world outcomes. This makes it particularly valuable for healthcare providers and pharmaceutical companies seeking to generate real-world evidence, optimize patient support programs, and better understand population-level dynamics in an observational, non-interventional framework.

Why we invested:

The continent has the highest epilepsy prevalence globally (2–3% vs. 0.5–1% elsewhere), yet African patient populations are dramatically underrepresented in clinical trials and real-world evidence datasets. Clarrio is building proprietary, high-resolution datasets from these populations and is increasingly valuable to global pharmaceutical companies seeking diverse real-world evidence for regulatory submissions. The team combines 30+ years of pharmaceutical industry experience from Merck with AI and machine learning expertise from InstaDeep, and a Microsoft partnership that provides access to hospital procurement channels across the GCC.

The Founders:

Firas Rhaiem is the CEO of Clarrio, he leads Clarrio.ai’s vision, strategic direction, and global expansion. An engineer by training with an MSc in Finance, he has built a strong track record across life sciences advisory, working with leading organizations such as IBM.

Dr. Ali Frederic Ben Amor is a Cofounder and Chief Strategy Officer of Clarrio, he is a globally recognized neurology and pharmaceutical executive with extensive experience in medical leadership and strategic healthcare innovation. He previously served as Senior Vice President (SVP) of Neurology, Immunology & Medical Affairs at Merck, where he led international medical operations and managed a portfolio generating approximately €500 million in annual revenue.

Dr. Karim Bendhaou is a Cofounder and the president of Clarrio, he is a seasoned pharmaceutical strategy leader with extensive executive experience across Africa and the MENA region. As Managing Director at Merck Northwest Africa, he led large-scale operations and regional market expansion initiatives.

Active in:

Pan African & USA